Home NDC 68382-751-96 temozolomide
Product NDC 68382-751
Requested package NDC 68382-751-96
11-digit product format 683820751
Labeler code 68382
Product ID 68382-751_2da71848-9a09-45b2-820e-c43f37b0fe3e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name temozolomide
Dosage form CAPSULE
Route ORAL
Labeler Zydus Pharmaceuticals USA Inc.
Application ANDA206750
Marketing category ANDA
Marketing start 2017-10-26
Marketing end 0000-00-00
Substance TEMOZOLOMIDE
Active strength 5 mg/1
Pharmacologic classes Alkylating Activity [MoA], Alkylating Drug [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68382-751 68382-751-96 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68382-751 68382-751-96 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206750-001 TEMOZOLOMIDE TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 A206750-002 TEMOZOLOMIDE TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 A206750-003 TEMOZOLOMIDE TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 A206750-004 TEMOZOLOMIDE TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 A206750-005 TEMOZOLOMIDE TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 A206750-006 TEMOZOLOMIDE TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 264 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206750-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A206750-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206750-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A206750-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206750-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206750-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206750-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206750-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206750-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206750-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206750-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2017-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206750-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2017-07-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206750-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2017-07-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206750-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2017-07-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206750-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2017-07-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206750-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2017-07-31 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 264 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68382-751-96 68382075196 5 CAPSULE in 1 BOTTLE (68382-751-96) 5 capsule 2017-10-26 0000-00-00 No No Current